ILMN - ILLUMINA, INC.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 122.28

Open

$ 120.48

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 119.29 - $ 123.73

52 Week Range

$ 89.00 - $ 213.91

Volume

829,331

Average Volume

Market Cap

19.32B

Beta (5Y Monthly)

$ 1.06

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-16-2024	12-31-2023	10-K
2	11-09-2023	10-01-2023	10-Q
3	08-10-2023	07-02-2023	10-Q
4	05-05-2023	04-02-2023	10-Q
5	02-17-2023	01-01-2023	10-K
6	11-04-2022	10-02-2022	10-Q
7	08-11-2022	07-03-2022	10-Q
8	05-05-2022	04-03-2022	10-Q
9	02-18-2022	01-02-2022	10-K
10	11-04-2021	10-03-2021	10-Q
11	08-05-2021	07-04-2021	10-Q
12	04-28-2021	04-04-2021	10-Q
13	02-17-2021	01-03-2021	10-K
14	10-30-2020	09-27-2020	10-Q
15	08-07-2020	06-28-2020	10-Q
16	05-01-2020	03-29-2020	10-Q
17	02-11-2020	12-29-2019	10-K
18	10-25-2019	09-29-2019	10-Q
19	07-31-2019	06-30-2019	10-Q
20	04-26-2019	03-31-2019	10-Q
21	02-12-2019	12-30-2018	10-K
22	10-24-2018	09-30-2018	10-Q
23	07-31-2018	07-01-2018	10-Q
24	04-25-2018	04-01-2018	10-Q
25	02-13-2018	12-31-2017	10-K
26	10-25-2017	10-01-2017	10-Q
27	08-03-2017	07-02-2017	10-Q
28	05-05-2017	04-02-2017	10-Q
29	02-14-2017	01-01-2017	10-K
30	11-08-2016	10-02-2016	10-Q
31	08-02-2016	07-03-2016	10-Q
32	05-09-2016	04-03-2016	10-Q
33	03-02-2016	01-03-2016	10-K
34	11-02-2015	09-27-2015	10-Q
35	07-31-2015	06-28-2015	10-Q
36	05-01-2015	03-29-2015	10-Q
37	02-18-2015	12-28-2014	10-K
38	10-29-2014	09-28-2014	10-Q
39	08-01-2014	06-29-2014	10-Q
40	05-07-2014	03-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Looking Into Illumina's Recent Short Interest
04/12/2024 15:45:26

EU Approved Illumina's Plan To Divest Grail
04/12/2024 09:48:48

https://ec.europa.eu/commission/presscorner/detail/en/ip_24_1964

Barclays Maintains Underweight on Illumina...
04/10/2024 19:30:52

Barclays analyst Luke Sergott maintains Illumina (NASDAQ:ILMN) with a Underweight and raises the price target from $85 to $100.

Stephens & Co. Reiterates Overweight on Il...
04/10/2024 12:38:30

Stephens & Co. analyst Mason Carrico reiterates Illumina (NASDAQ:ILMN) with a Overweight and maintains $170 price target.

Illumina Appoints Ankur Dhingra Chief Fina...
04/09/2024 20:05:57

ilmn

RBC Capital Reiterates Outperform on Illum...
04/09/2024 13:32:13

RBC Capital analyst Conor McNamara reiterates Illumina (NASDAQ:ILMN) with a Outperform and maintains $253 price target.

jim-cramer-isnt-going-with-this-tech-company-its-complicated-im-a-nvidia-guy

Jim Cramer Isn't Going With This Tech Comp...
04/08/2024 12:26:10

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).

GRAIL Presents New Data On Galleri And Its...
03/27/2024 13:03:48

New Data Will Highlight Use of GRAIL's Targeted Methylation Platform Across Early Cancer Detection and Precision OncologyLo...

eu-antitrust-regulators-overstepped-in-illumina-grail-deal-says-court-adviser

EU Antitrust Regulators Overstepped in Ill...
03/21/2024 17:56:09

EU antitrust advisor criticizes decision blocking Illumina's $7.1 billion bid for Grail, citing overreach. Impact on Qualco...

Illumina Shares Higher After Europe's Top ...
03/21/2024 11:54:17

-Reuters

OTR Global Downgrades Illumina to Mixed
03/20/2024 15:55:54

OTR Global downgrades Illumina (NASDAQ:ILMN) from Positive to Mixed.

GRAIL Announces Novel Risk Classification ...
03/18/2024 13:01:30

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, announced today that participant...

gene-sequencing-firm-illumina-escapes-carl-icahns-second-proxy-battle-amid-grail-divestment-efforts

Gene Sequencing Firm Illumina Escapes Carl...
03/13/2024 17:56:26

Carl Icahn halts new challenge to Illumina's board, sparing the gene sequencing giant a second proxy battle. Focus shifts t...

Carl Icahn Drops Threat To Challenge Illum...
03/12/2024 17:37:35

- Reuters

over-1m-bet-on-this-industrial-stock-check-out-these-4-stocks-insiders-are-buying

Over $1M Bet On This Industrial Stock? Che...
02/27/2024 13:47:52

Although U.S. stocks closed lower on Monday, there were a few notable insider trades.

Critical Insights From Illumina Analyst Ra...
02/14/2024 17:00:29

Stephens & Co. Reiterates Overweight on Il...
02/14/2024 16:23:01

Stephens & Co. analyst Mason Carrico reiterates Illumina (NASDAQ:ILMN) with a Overweight and maintains $170 price target.

Why Take-Two Interactive Software Shares A...
02/09/2024 18:18:14

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter res...

RBC Capital Reiterates Outperform on Illum...
02/09/2024 16:23:17

RBC Capital analyst Conor McNamara reiterates Illumina (NASDAQ:ILMN) with a Outperform and maintains $258 price target.

dna-sequencing-kit-provider-illuminas-q4-earnings-edge-above-street-estimates-works-to-resolve-grail-quickly

DNA Sequencing Kit Provider Illumina's Q4 ...
02/09/2024 14:32:18

Illumina exceeds Q4 2023 expectations with $1.12 billion sales, up 4% YoY. CEO Jacob Thaysen anticipates growth and outlines st...